Prevymis (letermovir) - Merck (MSD)
Breakthrough Cytomegalovirus Viremia During Letermovir Prophylaxis After Allogeneic Hematopoietic Stem Cell Transplantation: A Systematic Review and Meta-analysis (IDWeek 2026) - Sep 6, 2026 - Abstract #P - 2040; Pres time: Oct 23, 2026; 12:15 PM - 01:30 PM; Location: Virtual Presentation; No abstract available 
Retrospective data • Review • Cytomegalovirus Infection • Infectious Disease
https://idweek2026.eventscribe.net/fsPopup.asp?PosterID=837732&mode=posterInfo
 
Varshini Thiruvadi, MD; David Li, MD; Yanzhi Wang, PhD; Manasa Kandula, MD (she/her/hers); Denise Francisco, MD (she/her/hers)
 
Sep 6, 2026
 
Prev Next